SEC Form 4 · accession 0001093557-17-000089
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin R Sayer
Officer — President & CEO · Director
Period of report
Mar 17, 2017
Accepted (ET)
Mar 21, 2017 · 6:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 17, 2017 | M | 10,000 | $8.79 | A | 353,680 | D | |
| Common StockF1,F2,F3 | Mar 17, 2017 | S | 10,000 | $77.8158 | D | 343,680 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) | $8.79 | Mar 17, 2017 | M | 10,000 | D | Nov 6, 2008 | Nov 6, 2017 | Common Stock | 10,000 | 13,649 | D |
Explanation of responses
- F1On December 12, 2016, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- F2This transaction was executed in multiple trades at prices ranging from $77.16 to $78.75. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3Included in this number are 171,280 unvested restricted stock units, 81,280 of which were granted on March 8, 2017 and shall vest through March 8, 2020, 60,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019 and 30,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018.